Company: NDRA
Filing Date: 2025-10-30
Form Type: 424B5
Source: 0001213900-25-103705
Chunk: 3

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-30
Form: 424B5
Chunk 3
---
our” and the “Company” refer to ENDRA Life Sciences Inc. unless otherwise
stated or the context otherwise requires.

This prospectus supplement, and the information
incorporated herein by reference, may add, update or change information in the accompanying prospectus and in any free writing prospectuses
we may provide to you in connection with this offering. You should read both this prospectus supplement and the accompanying prospectus
together with additional information described under the headings “Where You Can Find More Information” and “Incorporation
of Certain Information by Reference.” If there is any inconsistency between the information in this prospectus supplement and the
accompanying prospectus, you should rely on the information in this prospectus supplement.

You may rely only on the information contained in or incorporated by reference in this prospectus supplement and the accompanying prospectus. Neither we nor the Sales Agent has authorized anyone to provide information different from that contained in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and therein. If anyone provides you with different or inconsistent information,
you should not rely on it. The information in this prospectus supplement, the accompanying prospectus and in any free writing prospectuses we may provide to you in connection with this offering is accurate only as of their respective dates, regardless of time of delivery. Our business, financial condition, results of operations and prospects may have changed since those dates.

We are offering to sell, and seeking offers to
buy, our securities only in jurisdictions where offers and sales are permitted. The distribution of this prospectus supplement and the
offering of the securities in certain jurisdictions may be restricted by law. Persons outside the United States who come into possession
of this prospectus supplement must inform themselves about, and observe any restrictions relating to, the offering of the securities and
the distribution of this prospectus supplement outside the United States. This prospectus supplement does not constitute, and may not
be used in connection with, an offer to sell, or a solicitation of an offer to buy, any securities offered by this prospectus supplement
by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation.

All references in this prospectus to our consolidated
financial statements include, unless the context indicates otherwise, the related notes.

We further note that the representations, warranties
and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference herein were made
sole